Form 4: IMAX Chief Legal Officer Exercises, Sells Shares

Sentiment:

Insider Transaction Report 7 November 2025 4:07 PM

IMAX's Chief Legal Officer, Robert D. Lister, exercised stock options and subsequently sold 50,143 common shares on November 7, 2025, under a 10b5-1 plan.

Summary

Robert D. Lister, Chief Legal Officer and Sr Exec VP of IMAX Corp, reported transactions executed under a Rule 10b5-1 plan.
On November 7, 2025, Lister exercised 50,143 stock options at a price of $22.49 per share, converting them into common shares.
Concurrently, he sold 50,143 common shares at an average price of $34.6652 per share.
These transactions were executed pursuant to a 10b5-1 Plan established on June 11, 2025.
Following these transactions, Lister's direct beneficial ownership of common shares is 161,421, and his remaining restricted share units total 70,609.
The exercised stock options were originally issued in 2019 and were set to expire on March 7, 2026.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The transaction is a routine executive compensation event, realizing value from options. The sale is part of a pre-planned strategy, not necessarily indicative of a negative outlook, but also not a strong positive signal like an open market purchase.

Positives

The exercise of options indicates the executive is realizing value from previously granted equity compensation.
The sale price of $34.6652 is significantly higher than the exercise price of $22.49, indicating a substantial gain for the executive.

Negatives

The sale of shares by a senior executive, even if pre-planned, could be interpreted as a reduction in their direct equity exposure to the company.

Future Outlook

Industry Context

Stakeholder Impact

Shareholders: The sale of shares by a senior executive, even if pre-planned, could be viewed with mixed sentiment, though it is a common practice for executives to diversify holdings and realize compensation value.

Key Dates

Date	Description
2019	Stock options were issued.
March 7, 2020	First installment of 12,535 stock options became exercisable.
March 7, 2021	Second installment of 12,535 stock options became exercisable.
March 7, 2022	Third installment of 12,535 stock options became exercisable.
March 7, 2023	Fourth installment of 12,538 stock options became exercisable.
June 11, 2025	Date of the 10b5-1 Plan.
November 7, 2025	Date of stock option exercise and common share sale.
March 7, 2026	Expiration date of the stock options.

Recommendation

hold

This Form 4 filing details a routine exercise and sale of stock options by a senior executive under a pre-arranged 10b5-1 plan. Such transactions are common for executive compensation and do not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation. The executive is realizing value from previously granted equity, which is expected. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide new information to alter an existing investment thesis.

Keywords

IMAX, Insider Trading, Form 4, Stock Options, Equity Compensation, Robert D. Lister, 10b5-1 Plan, Share Sale, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.